Combining MyoCI With Memory Reactivation to Improve Motor Recovery After Stroke
Launched by NORTHWESTERN UNIVERSITY · Mar 16, 2020
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new approach to help people who have had a stroke improve their arm movement. The researchers are combining myoelectric computer interface (MyoCI) training, which uses a special device to help track and improve muscle activity, with a technique called targeted memory reactivation (TMR) that takes advantage of sleep to boost learning. The goal is to see if this combination can lead to better arm motor function over time for those who have had a stroke.
To participate, you need to be at least 21 years old and have had your first stroke at least six months ago, resulting in some difficulty moving your arm. You should be able to move your shoulder and elbow muscles a little. If you have serious vision issues or cannot follow instructions, this study might not be for you. Participants can expect to engage in training sessions lasting about 90 minutes each day, and they'll be closely monitored to see how well this new training method helps improve their arm function. This trial is currently recruiting participants, so if you meet the criteria and are interested, you could contribute to important research in stroke recovery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age at enrollment is 21 or older
- • Hemiparesis from first ever stroke affecting arm movement at least 6 months prior to screening
- • Severe to moderate motor impairment (FMA-UE of 7-40)
- • At least some voluntary shoulder and elbow muscle activation
- Exclusion Criteria:
- • Inability to follow instructions of the MyoCI task
- • Visual impairment (such as hemianopia) preventing full view of screen
- • Anesthesia or neglect in the affected arm, or visual hemineglect (score of 2 on the NIH Stroke Scale Extinction and Inattention subtest)
- • Participation in another study on the affected arm within 6 weeks of enrollment or any pharmacological study
- • Inability to understand or follow commands in English due to aphasia or other reason
- • Diffuse or multifocal infarcts in both hemispheres
- • Substantial arm pain preventing participation for 90 minutes a day
- • Spasticity treatment (pharmacological or Botox) within last 3 months
- • Ferromagnetic implants that are MRI incompatible
About Northwestern University
Northwestern University is a prestigious academic institution renowned for its commitment to advancing medical research and improving patient care through innovative clinical trials. With a robust infrastructure that supports interdisciplinary collaboration, Northwestern leverages its expertise in various fields, including medicine, engineering, and social sciences, to drive groundbreaking studies. The university is dedicated to adhering to the highest ethical standards and regulatory compliance, ensuring that all clinical trials are conducted with the utmost integrity and focus on participant safety. Through its Clinical Trials Office, Northwestern aims to translate scientific discoveries into effective therapies, ultimately enhancing health outcomes and contributing to the broader medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chicago, Illinois, United States
Patients applied
Trial Officials
Marc W Slutzky, MD/PhD
Principal Investigator
Northwestern University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials